Handwriting difficulties of children with Charcot-Marie-Tooth disease type 1A

Daniel Kunovsky1, Reinie Cordier2, Paula Bray1,3

  • 1Faculty of Health Sciences, University of Sydney, Sydney, NSW, Australia.

Insights

Children with Charcot-Marie-Tooth disease type 1A (CMT1A) experience significantly slower handwriting speed and reduced legibility due to hand weakness. This study highlights the impact of CMT1A on fine motor skills in affected children.

Area of Science:

  • Neurology
  • Pediatrics
  • Rehabilitation Medicine

Background:

  • Charcot-Marie-Tooth disease type 1A (CMT1A) often presents with upper limb dysfunction in children.
  • Impaired hand function in CMT1A can lead to difficulties with essential daily activities, including handwriting.
  • Early assessment of handwriting is crucial for children with CMT1A to guide therapeutic interventions.

Purpose of the Study:

  • To investigate the effects of CMT1A on handwriting speed and legibility in children.
  • To identify demographic, anthropometric, and physical factors associated with handwriting performance in CMT1A.
  • To determine predictors of impaired handwriting in pediatric CMT1A.

Main Methods:

  • Assessed handwriting speed and legibility in 30 children with CMT1A and 30 controls.
  • Measured hand strength (tip pinch, lateral pinch, grip) using hand-held dynamometry.
  • Analyzed associations between strength, anthropometrics, age, and handwriting using correlation and regression.

Main Results:

  • Children with CMT1A demonstrated 34% slower handwriting speed and 4% reduced legibility compared to controls.
  • Significant hand and finger weakness (37-48% lower) was observed in children with CMT1A.
  • CMT1A diagnosis, lateral pinch weakness, and younger age were independent predictors of slower handwriting speed.

Conclusions:

  • Children with CMT1A exhibit significant challenges with handwriting speed and legibility, linked to hand and finger weakness.
  • Hand strength and age are key factors influencing handwriting speed in this population.
  • Identifying the relationship between strength deficits and functional outcomes can inform targeted upper limb interventions for CMT1A.